For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Shinhan Financial Group Co., Ltd. (SHG) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-08-27): Designation Watch · Gem Score +19 (−100…+100 Quality+Value blend) · Quality 24 · Value 16 · Sentiment 0 (timing only, not weighted) · Composite fair value $83.69 vs $76.81 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Shinhan Financial Group Co., Ltd.
SHG NYSEShinhan Financial Group Co., Ltd. American Depositary Receipt is the U.S.-traded depositary receipt for Shinhan Financial Group, a South Korea-based financial holding company headquartered in Seoul. The company provides a broad range of banking and financial services through its subsidiaries, including retail and commercial banking, corporate lending, wealth management, insurance, and related financial support services. Its business model centers on serving individual customers, businesses, and institutional clients across South Korea and selected international markets. Shinhan Financial Group also operates within the wider financial services sector, where it plays a key role as a diversified banking group offering deposits, loans, payment services, and asset management products. As an American Depositary Receipt, SHG gives U.S. market participants exposure to the group’s operations through a U.S.-listed security while reflecting the performance of the underlying Korean financial institution.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 6.95
Total Equity: $42.48B
Shares: 506,681,716
Total Debt: $0.00
Cash: $25.45B
EBITDA: N/A
Total Debt: $0.00
Cash: $25.45B
Revenue: $13.03B
Revenue: $13.03B
Revenue: $13.03B
Total Equity: $42.48B
Tax Rate: 26.6%
Equity: $42.48B
Total Debt: $0.00
Cash: $25.45B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $42.48B
Shares: 506,681,716
Shares: 506,681,716
CapEx: -$190.53M
Shares: 506,681,716
Stock Price: $76.81
Net Income: $3.52B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 24, 2026 7:15am (28d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $15.4B | $41.7B | $43.4B | $52.5B | $13.0B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $8.6B | $4.3B | $4.2B | $4.3B | $3.7B |
| Operating Income | — | $4.2B | $4.3B | $4.6B | — |
| Net Income | $2.8B | $3.3B | $3.1B | $3.2B | $3.5B |
| EBITDA | — | — | — | — | — |
| EPS | $5.18 | $6.46 | $5.70 | $5.98 | $6.95 |
| EPS (Diluted) | $5.18 | $6.46 | $5.70 | $5.98 | $6.95 |
Balance Sheet (Annual)
Last updated: Aug 26, 2026 2:30am (26d ago)| Metric | 2021 | 2022 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | $9.4B | — | $17.3B | $22.0B | $25.5B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $468.1B | $463.5B | $463.5B | $499.6B | $534.2B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $432.3B | $427.3B | $427.3B | $458.9B | $491.8B |
| Total Equity | $35.8B | $36.3B | $36.3B | $40.7B | $42.5B |
| Retained Earnings | $22.1B | $22.5B | $22.5B | $26.3B | $28.2B |
Cash Flow (Annual)
Last updated: Aug 26, 2026 2:30am (26d ago)| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$3.2B | $8.0B | $5.5B | $382.6M | $3.3B |
| Capital Expenditure | -$202.0M | -$241.8M | -$235.8M | -$188.8M | -$190.5M |
| Free Cash Flow | -$3.4B | $7.8B | $5.2B | $193.8M | $3.2B |
| Acquisitions (net) | -$52.8M | $0 | -$20.1M | $0 | $0 |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | -$699.7M | -$880.2M | -$1.1B | -$1.1B | -$915.1M |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | $277.2M | $3.0B | -$73.7M | $4.3B | $3.5B |
Growth Trends (YoY %)
Last updated: Aug 24, 2026 7:15am (28d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +169.9% | +4.3% | +20.8% | -75.2% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | +3.6% | +5.9% | — |
| Net Income Growth | +15.5% | -5.9% | +1.9% | +11.7% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 26, 2026 2:30am (26d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2025-08-01 | $0.41 | — | — | — |
| 2025-05-02 | $0.41 | — | — | — |
| 2025-02-21 | $0.38 | — | — | — |
| 2024-09-30 | $0.39 | — | — | — |
| 2024-06-28 | $0.39 | — | — | — |
| 2024-03-27 | $0.39 | — | — | — |
| 2024-03-20 | $0.39 | — | — | — |
| 2024-02-22 | $0.40 | — | — | — |
| 2023-09-28 | $0.39 | — | — | — |
| 2023-06-29 | $0.40 | — | — | — |
| 2023-03-30 | $0.39 | — | — | — |
| 2022-12-29 | $0.66 | — | — | — |
| 2022-09-29 | $0.28 | — | — | — |
| 2022-06-29 | $0.30 | — | — | — |
| 2022-03-30 | $0.31 | — | — | — |
| 2009-03-16 | $0.41 | — | — | — |
| 2005-12-28 | $0.83 | — | — | — |
| 2004-12-29 | $0.74 | — | — | — |
| 2003-12-29 | $0.52 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Not computed yetNarrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-26 04:02The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The revenue numbers in this file are unusable as a growth signal. 2021 shows $15.44B, then $41.67B/$43.45B/$52.47B for 2022-2024, then $13.03B for partial 2025 — that's not a -45.2% CAGR, that's an FMP reporting-basis flip (interest income vs. total interest-and-fee income, or gross vs. net of interest expense) compounded by KRW/USD translation. Any model citing "recent_revenue_yoy: -75.2%" as signal is reading noise. The only fundamentals worth anchoring to are net income (remarkably stable at $2.85B → $3.29B → $3.09B → $3.15B → ~$3.5B run-rate 2025), equity base ($42.48B), and the resulting ~7.4% ROE on book. That's the actual business: a low-teens-ROE Korean money-center bank grinding out ~$3.1-3.5B a year with modest earnings growth (6.7% CAGR is probably the one clean number here).
At $76.81 with an $36.2B cap against $3.3B normalized NI, you're paying 11x earnings for a bank trading at ~0.85x book with a 2.07% dividend yield (the narrative layer's "12% dividend yield" claim is wrong — FMP shows 2.07%, and Korean banks typically pay 4-6%, so someone's decimal slipped). The synthesis calling $83.77 fair value (+9%) is roughly where a mechanical peer-multiple exercise lands, but I'd push back: Korean bank multiples have been stuck at 5-7x P/E and 0.4-0.5x book for a decade for structural reasons — chaebol governance discount, FSC-mandated capital retention, KRW depreciation risk against USD (KRW is down ~15% vs USD over five years, which silently eats ADR returns), and the "Value-Up" program's uncertain follow-through. SHG at 11x and 0.85x book is actually toward the *high end* of its historical range, not the discount the pre-flight thesis implies. Comparing it to US regionals at 15-18x P/E ignores that US regionals earn 12-15% ROEs, not 7-8%.
The contrarian case the models are missing: this isn't a discount-to-peers story, it's a stock that has already re-rated on Korean corporate reform optimism (Value-Up disclosures, buyback expansion, ~$36B cap is near multi-year highs in USD terms). The narrative layer correctly flags "quiet-quality/minimal intensity" but then the synthesis quietly assumes multiple expansion. Where's it coming from? If Korean rates keep falling (BOK cutting cycle underway), NIM compresses; if the KRW weakens further on the trade war / semiconductor cycle, ADR holders lose regardless of local performance; if real estate PF exposure surfaces more losses (this has been the recurring 2023-2024 write-down driver at Korean banks), the earnings floor cracks. The "fortress balance sheet" story is fine until Korean CRE marks reset.
I partially dissent from the synthesis $83.77 fair value. My read: SHG is fairly valued to modestly rich here — ~$70-78 is the honest range for a 7.4% ROE bank with FX overhang and structural low-growth. The +9% upside the composite prints is inside translation-and-multiple noise, and the "growth is effectively free" line is an artifact of the broken revenue series feeding a no-growth floor calculation. The 2.07% yield doesn't compensate for waiting, and there's no catalyst asymmetry — Value-Up is priced in, rate cuts are a headwind, and the ADR adds FX beta you're not paid for. I'd rather own a US regional at 10x with a domestic-currency 4% yield than SHG at 11x with FX risk and a 2% yield. Not a short — the book value support and buyback trajectory are real — but not the +9% mispricing the composite claims.
GPT Reading
The first thing I would throw out is the revenue line as a valuation anchor. A bank showing revenue of $52.47B in 2024, $43.45B in 2023, $15.44B in 2021, and then $13.03B for 2025 while net income stays clustered around $2.85B-$3.52B is not telling an economic story of boom, collapse, and recovery; it is telling a reporting-definition story. The same applies to the computed -45.2% revenue CAGR and -75.2% recent revenue decline. For a bank, net interest income, fee income, trading marks, and accounting presentation can make “revenue” a poor cross-period measure, especially in ADR data feeds. What looks much more reliable is that Shinhan has produced roughly $3B-plus of annual earnings for five straight years: $2.85B, $3.29B, $3.09B, $3.15B, and now $3.52B. That is a modest but real earnings base, not a broken franchise. Against a $36.17B market cap, the stock is on about 10-11x earnings, with $42.48B of equity on the balance sheet, so the market is valuing the business at roughly 0.85x book and about 9.7% earnings yield. For a profitable, well-capitalized bank, that is not expensive.
What stands out to me is that the stock is being priced like a no-growth or low-quality bank, while the income line suggests a fairly resilient one. 2024 free cash flow of $3.15B and operating cash flow of $3.34B are directionally supportive, though I would never over-index on bank FCF the way I would for an industrial. The more important point is that earnings have not only held but improved, with 2025 net income at $3.52B, up about 11.7% year over year from $3.15B. If that number is even broadly representative, then paying 11x earnings and below book for a bank compounding earnings mid-single digits is a decent entry, especially with $25.45B of cash and equivalents adding balance-sheet comfort. The dividend yield shown at 2.1% is oddly low for a Korean bank and likely reflects data issues or ADR mechanics, so I would not use that as the core of the thesis. The core thesis is simpler: the market is discounting Shinhan for geography, banking cyclicality, and data opacity, but the actual earnings history argues for a steadier and cheaper franchise than the screeners imply.
I also think the prior “fair value” output near $83.77 is too timid because it gives too much credence to corrupted top-line signals and too little to the book-and-earnings relationship. If the business can sustainably earn $3.3B-$3.5B on $42.48B of equity, that is roughly 7.8%-8.3% ROE based on the numbers here—not elite, but respectable enough that a sub-book multiple looks conservative rather than fair. Even assigning only 11.5x to 12x sustainable earnings on $3.4B gets you to roughly $39B-$41B in equity value, or around 8%-14% above the current market cap before considering that the 2025 profit appears to be the best in the series. A move to just 0.95x book would imply about $40.4B of value, again comfortably above today’s $36.17B. That is not a screaming mispricing, but it is enough to call the shares undervalued rather than merely fair, particularly because the downside seems cushioned by the current discount to equity.
The best case against this view is that the discount exists for very good reasons and the reported stability is lower quality than it looks. A smart bear would point to the weak cash-flow-quality flag, the unusable revenue series, the low confidence in quarterly trends, and the possibility that Shinhan’s earnings are more exposed than they appear to Korean real estate, consumer credit stress, regulatory pressure on bank spreads, and FX translation. They would also note that an 8%-ish ROE is not strong enough to demand book value, let alone a premium, and that a 10-11x P/E is not especially cheap if earnings are cyclically elevated near the top of a rate cycle. On that reading, the stock is not mispriced; it is simply correctly discounted for mediocre structural growth, political and currency risk, and potential normalization in margins. I take those objections seriously, but I weigh them less heavily because the actual multi-year earnings record has already spanned varied rate and credit conditions without any collapse in profitability. This does not look like a value trap built on one anomalous year.
What would change my mind is straightforward. If the next annual result shows net income falling back below about $3.0B, or if equity materially erodes from $42.48B without a compensating jump in payouts, then the sub-book multiple would look deserved rather than opportunistic. Likewise, if management’s next disclosures reveal meaningful credit deterioration or reserve-building severe enough to push ROE toward 6%-7%, I would stop arguing for re-rating. On the other hand, if Shinhan can sustain earnings around $3.4B-$3.6B and keep equity stable, I think the stock should at least migrate toward 0.95x book or about 12x earnings, which supports a share price in the low-to-mid $80s and leaves room beyond that if capital returns are better than this dataset suggests.
Grok Reading
The income statement noise is the first thing that jumps out, and it is almost entirely noise. Revenue lurches from $15.44B in 2021 to $41–52B in 2022–24 then collapses to a $13.03B 2025 print, producing a meaningless −45% revenue CAGR and a −75% recent year-over-year drop; net income, by contrast, has marched steadily from $2.85B to $3.09B to $3.15B to $3.52B. That is a clean 6.7% earnings CAGR and an 11.7% latest-year lift on a $36.17B market cap—roughly 10–11× trailing earnings at the $76.81 print. Operating cash flow of $3.34B and free cash flow of $3.15B against only $190M of capex confirm that the earnings are cash, not accounting fiction. Equity of $42.48B and $25.45B of cash further anchor a fortress-style balance sheet typical of a large Korean universal bank. The story the clean numbers tell is a mature, high-teens-to-mid-twenties net-margin franchise (depending on which revenue base one trusts) that is simply compounding book value and returning capital at a modest 2.1% dividend yield while the market applies an 11× multiple that sits well below US regional and even Japanese mega-bank comps.
The quantitative models’ “fair value ~$83.70 / +9%” and “mature earner” labels are therefore directionally right, but they understate how much of the discount is already explained by data-quality and Korea-country-risk haircuts rather than by deteriorating fundamentals. Once the ADR-translation and gross-versus-net revenue reporting artifacts are stripped out, Shinhan is a stable ~$3.2–3.5B annual earner whose free cash flow roughly equals reported net income; at $76.81 the stock is priced as if that earnings power is permanently impaired. Sector intelligence flagging “above sector benchmarks” and a net margin that, on the cleaner years, sits comfortably in the mid-teens to high-twenties range further support the view that the franchise itself is intact. The valuation synthesis correctly notes that the shares trade below a no-growth floor, which means any loan-growth recovery, wealth-management mix shift, or even simple currency stabilization is effectively free optionality.
The strongest counter-argument is straightforward and must be taken seriously: South Korean banks face structural headwinds—aging demographics, low nominal loan growth, net-interest-margin compression in a lower-rate regime, and rising fintech and internet-bank competition—that can keep earnings flat for years even if credit costs stay benign. The −22.5% FCF CAGR and “weak cash-flow quality” flag, if they reflect anything real rather than the same reporting discontinuity, would imply that the recent $3.15B FCF print is not a sustainable run-rate. Macro headwinds and the explicit Korea geopolitical/regulatory discount are not imaginary; a 40–50% multiple gap versus developed-market peers can persist indefinitely if local ROE remains capped in the high single digits and the won remains a volatile funding currency for ADR holders. A smart opponent would also note that the 2.1% yield is hardly compelling compensation for that risk, and that the narrative layer itself is “quiet-quality” with minimal intensity—exactly the setup in which a value trap can grind lower for years without a catalyst. I weigh those points as real but already mostly in the price: an 11× earnings multiple on growing, cash-backed NI already embeds a heavy country and growth haircut; the same data that look weak on a multi-year FCF CAGR look solid on a spot FCF-to-NI conversion near 100%.
What would flip the verdict is a clear break in the earnings floor—two consecutive half-years of NI below ~$2.8B, a material rise in NPL formation tied to Korean real-estate or household leverage, or a sustained won depreciation that turns the ADR into a pure currency short—or, on the upside, a re-rating catalyst such as a credible multi-year ROE expansion above 10–11% or a capital-return step-up that lifts the dividend yield into the mid-single digits while earnings keep compounding. Until one of those arrives, the asymmetry at $76.81 versus mid-80s fundamental value and a clean $3B-plus earnings base favors the patient buyer.
Qwen Reading local experiment · off-panel
The single most important thing in this briefing is that the revenue data is broken, and nearly every derived metric that touches revenue is therefore unreliable. The five-year revenue series — $15.44B, $41.67B, $43.45B, $52.47B, $13.03B — is not a business trajectory; it is a data pipeline failure, almost certainly a currency-conversion or double-counting error in the ADR reporting layer. The "revenue_cagr: -45.2%" and "recent_revenue_yoy: -75.2%" figures that the momentum engine spat out are artifacts of that corruption, not evidence of a collapsing franchise. What survives the data noise is the net income line: $2.85B, $3.29B, $3.09B, $3.15B, $3.52B. That is a remarkably stable earnings stream for a $36B market-cap bank, with a 6.7% five-year CAGR and a 2025 print that is the highest in the series. Operating cash flow of $3.34B tracking within 6% of net income tells me the earnings are real, not accounting alchemy. The "Weak Cash Flow Quality" flag in the secondary signals is, I believe, a downstream casualty of the revenue corruption rather than a genuine red flag, because the CF-to-NI ratio is textbook healthy.
On valuation, the number that matters most for a bank is price-to-book, and the data gives me that cleanly: $36.17B market cap against $42.48B of total equity is roughly 0.85x book. That is below the 1.0x threshold, which for a top-three Korean universal bank with 27% net margins and no visible leverage distress is a genuine discount, not a "fair value" as the synthesis model labels it. The 11.05x P/E on the 2025 earnings of $3.52B implies the market is assigning essentially zero growth premium to a bank that just posted its best year in the five-year window. The 2.07% dividend yield is unglamorous, but I want to flag that the bear narrative's "12% dividend yield" claim is irreconcilable with the canonical data and should be discarded as an error. The real yield is modest, which means the stock is not being bought on income alone; it is being bought on the P/B discount and the earnings stability, which is a more durable thesis.
The strongest case against my read is the structural Korea discount, and I will not wave it away. Korean banks trade at a persistent 30-50% P/B discount to their Japanese and Western peers, and the reasons are not imaginary: regulatory risk around government-directed lending, genuine real-estate credit exposure in a market where household debt-to-GDP sits near 90%, KRW currency risk for ADR holders, and the ever-present North Korea overhang. A smart opponent would point to the 0.85x P/B and say, "That's not a discount, that's the correct price for a bank whose government can reprice its loan book overnight or force it to absorb sovereign debt." They would also note that the "Above Sector Benchmarks" sector signal is thin comfort when the entire Korean banking sector is the discount, and that the 2.07% yield offers no cushion if KRW slides another 5-8% against the dollar. I weigh this differently because Shinhan's equity base of $42.48B against a market cap of $36.17B means I am buying $1 of book value for 85 cents, and the earnings power to regenerate that book at 27% margins is not a function of Korean policy — it is a function of deposit-and-lending spread economics that have held for five straight years. The discount is real, but it is not infinite, and it has not widened despite the 2025 earnings beat.
What would change my mind is specific and testable. A quarterly net income print below $750M (implying an annualized run-rate under $3B) would break the stability thesis and confirm that the 2025 print was a one-off rate-cycle tailwind rather than a new floor. A KRW move below 1,450/USD would compress the ADR's dollar earnings and make the 11x P/E look like 13x in local-currency terms, erasing the value case. And a regulatory announcement capping Shinhan's payout ratio or mandating additional capital buffers would directly attack the 0.85x P/B as a floor rather than a discount, because the equity base would be artificially inflated. None of these are on the near-term calendar, but they are the three numbers I would watch in the next two earnings reports.
The valuation synthesis model's "fair_value" verdict at $83.69 is, in my view, too conservative. It is anchored to a composite that blends the corrupted revenue data with the clean earnings data, and the "methods disagree" caveat is doing a lot of quiet work to justify a middling number. The no-growth DCF floor, which the model itself notes the stock trades below, is the more honest anchor: if Shinhan earns $3.5B forever and I discount at 10%, the equity value is roughly $35B, which is where we are. The fact that the stock is at that floor means the market is paying nothing for the 6.7% earnings CAGR, the 27% margin, or the balance-sheet quality. That is not fair value; that is a price that assumes the worst. I am not table-pounding, because the data quality is genuinely poor enough that I cannot underwrite a 20-30% upside with confidence, but the direction is clear.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Shinhan Financial is a mature Korean banking franchise generating consistent net income in the 3.0-3.5B USD range across five years (2.85B in 2021 rising to 3.52B in 2025) on a large and stable earnings base. Liquid assets of 25.45B against market cap of 36.2B and diluted share count trending down at roughly 2% CAGR indicate disciplined capital return, with per-share value being concentrated rather than diluted. Operating margins in the 8.7-10% band are typical for regional banks and show no obvious deterioration.
Verify before trusting this (5)
- Reconcile the 2025 revenue drop to 13.0B - is this a partial-year figure or a classification change?
- Confirm regulatory capital ratios (CET1, Tier 1) from the annual report to gauge true balance-sheet strength.
- Check non-performing loan trends and provisioning coverage in Korean banking disclosures.
- Verify whether the -2% diluted share CAGR reflects buybacks or reverse-split/technical share adjustments.
- Examine exposure to Korean real estate project financing, which has been a stress point sector-wide.
The composite fair value of $83.69 (signal-adjusted $83.77) sits about 9% above the $76.81 price. That is a real but not thrilling margin of safety for a large Korean bank whose earnings are stable in the low-3B USD range and whose share count is drifting down. The EPV floor of $120.71 hints at deeper value if you believe earnings are durable, but bank EPV runs hot and I would not lean on it; the anchored-PE of $46.67 pulls the other way and reflects the persistent Korea-discount the market has assigned for years.
Verify before trusting this (4)
- NIM trajectory and loan-growth guidance in the next earnings release
- Capital return policy - buyback pace and dividend sustainability given the ~12% headline yield claim
- Provisioning trends and any KRW property/PF exposure
- FX (KRW/USD) trend which drives the ADR price independent of fundamentals
SHG lives in the dead zone of market attention: a low-beta (0.64), low-intensity quiet-quality archetype with a durable but sleepy dividend-and-safety story. In a mildly risk-on tape that would normally be neutral for a name like this, the real pressure is coming from underneath the story - momentum has cratered (-75% recent vs -45% long-term CAGR), meaning the tape is actively marking this ADR down regardless of the fundamental thesis. That is classic value-trap sentiment: the narrative says 'safe yield,' the price action says 'nobody wants it.' Macro cross-currents amplify the headwind selectively. A 4.7% 10y and 25.7 market PE are generic equity headwinds, but for a Korean bank ADR they layer on FX/won risk and the bear-case worry that yield is masking stagnant earnings. Low cult coefficient and minimal narrative intensity mean there is no fanbase to catch the falling knife, and analyst tone on Korean regional banks is structurally tepid - no one is upgrading into demographic decline and fintech share loss. Net: not a crash setup, but a persistent, unglamorous headwind. The stock has no story pulling capital in, an actively deteriorating price trend, and macro/FX friction the ADR buyer feels directly. The risk-on regime helps the market, not this name.
None surfaced.
None surfaced.
The world is handing Korean banks a mixed hand: macro headwinds with a high global long rate (10y 4.7) and a thin curve (0.46) pressure spreads, while domestic easing caps NIM. Offsetting that, Korea's governance/value-up reform cycle is structurally re-pointing large financials toward buybacks, cancellation and higher payout ratios — a policy tailwind that mechanically raises per-share earnings without needing loan growth. Rising household financial assets and deeper retail capital-market participation support fee lines. Net: a low-growth, high-payout, mature-oligopoly regime where earnings power holds and per-share figures inch up, rather than a franchise in decline or in expansion.
When we made this prediction on Aug 26, 2026, SHG was $77.34. We expect it to be $83.20 by Feb 2027, and we consider it great value under $68.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 26, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.